Who are Vivos Therapeutics, Inc.'s main suppliers?

Vivos Therapeutics, Inc. (VVOS) key suppliers include: V-CO-INVESTORS-3-LLC, V-CO-INVESTORS-4-LLC, NEW-SENECA-PARTNERS-INC, V-CO-2, V-CO-INVESTORS-LLC and 2 more. View the full supplier network at chainsifter.com/chain/VVOS.

Who are Vivos Therapeutics, Inc.'s major customers?

Vivos Therapeutics, Inc. (VVOS) key customers include: V-CO-INVESTORS-3-LLC. View the full customer network at chainsifter.com/chain/VVOS.

What sector is Vivos Therapeutics, Inc. in?

Vivos Therapeutics, Inc. (VVOS) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

VVOS Supply Chain: Vivos Therapeutics, Inc. Supplier List & 11 Relationships

7Suppliers

1Customers

3Debt Items

0Related Chains

Vivos Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
V-CO-INVESTORS-3-LLC	V-CO-INVESTORS-3-LLC	92%	Vivos Therapeutics, Inc. entered into an unsecured convertible promissory note in favor of V-Co Investors 3 LLC
V-CO-INVESTORS-4-LLC	V-CO-INVESTORS-4-LLC	92%	V-Co Investors 4 LLC funded an initial $500,000 to the Company under the V-Co 4 Note
NEW-SENECA-PARTNERS-INC	NEW-SENECA-PARTNERS-INC	90%	V-Co is an affiliate of New Seneca Partners Inc., an existing private equity investor in, and advisor to, the Company
V-CO-2	V-CO-2	90%	Pursuant to the June 2025 PIPE SPA, the Company sold to V-Co 2 in a private placement offering
V-CO-INVESTORS-LLC	V-CO-INVESTORS-LLC	90%	Pursuant to the June 2024 SPA, we sold to V-CO in a private placement offering
H-C-WAINWRIGHT-CO-LLC	H-C-WAINWRIGHT-CO-LLC	80%	H.C. Wainwright & Co., LLC (" HCW "), pursuant an engagement agreement with us, dated May 2, 2024 and amended on August 2, 2024 acted as the exclusive placement agent
SENECA	SENECA	80%	V-CO is an affiliate of Seneca, a leading independent private equity firm

Vivos Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
V-CO-INVESTORS-3-LLC	V-CO-INVESTORS-3-LLC	90%	Pursuant to the PIPE SPA, the Company sold to V-Co 3 in a private placement offering

Vivos Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
VVOS-DEBT	Debt stack $13.5M	90%	Market cache reports total debt of $13.5M.
VVOS-DEBT-13471	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.
VVOS-DEBT-13470	Warrants outstanding: 16000	90%	xbrl warrant detail from xbrl 2025-12-31.

Vivos Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Vivos Therapeutics, Inc..

Vivos Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
VVOS-OWNER-ARMISTICE-CAPITAL-LLC	ARMISTICE CAPITAL, LLC	90%	13F overlay lists ARMISTICE CAPITAL, LLC as top holder; 25 tracked holders.

Vivos Therapeutics, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.

Vivos Therapeutics, Inc. Supply Chain